See also this year's filing and all EDGAR filings for this company.
PDF Report 0001498068_2017_American_Renal_Associates_Holdings_Inc.pdf
Logs
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.03077834366053229, 'aggregate_val': 709996000, 'exp_sum': 688796000, 'exp_to_value': {'LongTermLiabilities': 533728000, 'LiabilitiesCurrent': 153790000, 'remainder_Liabilities': 1278000}} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001498068')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001498068, American Renal Associates Holdings Inc.
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 598,773,000 |
1 | AssetsNonCurrent | 6,753,000 |
2 | AssetsCurrent | 210,380,000 |
3 | PropertyPlantAndEquipment | 170,118,000 |
4 | remainder_Assets | 0 |
5 | LongTermLiabilities | 533,728,000 |
6 | LiabilitiesCurrent | 153,790,000 |
7 | remainder_Liabilities | 22,478,000 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 127,631,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 0 |
13 | DepreciationDepletionAndAmortization | 33,862,000 |
14 | SellingAndMarketingExpense | 0 |
15 | ResearchAndDevelopmentExpense | 0 |
16 | remainder_Expenses | 460,714,000 |
17 | remainder_Revenues | 1,286,000 |
18 | remainder_NetIncome | 709,126,000 |
19 | remainder_ComprehensiveNetIncome | -88,189,000 |
yvar | yval | |
---|---|---|
0 | Assets | 986,024,000 |
1 | Liabilities | 709,996,000 |
2 | Expenses | 622,207,000 |
3 | Revenues | 1,286,000 |
4 | StockholdersEquity | 276,028,000 |
5 | NetIncome | 88,205,000 |
6 | ComprehensiveNetIncome | 16,000 |
7 | BaseVar | 1,792,847,320 |
8 | EconomicCapitalRatio | 0.550 |